Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Kiyomi Mera"'
Autor:
Toru Mukohara, Kazuhiro Araki, Keiji Kodama, Kiyomi Mera, Hirofumi Mukai, Yuichi Ando, Masaru Narabayashi, Yasutsuna Sasaki, Koichi Kitagawa, Hironobu Minami
Publikováno v:
Investigational New Drugs. 30:2327-2333
Purpose Sagopilone has recently been identified and preferentially used for the treatment of taxane-resistant cancer. The purpose of this dose-escalation study was to investigate the safety, tolerability, and pharmacokinetics (PK) of sagopilone in re
Autor:
Satoshi Takeuchi, Makoto Tahara, Keiko Minashi, Keiji Nihei, Atsushi Ohtsu, Tomonori Yano, Manabu Muto, Toshihiko Doi, Takashi Kojima, Kiyomi Mera
Publikováno v:
American Journal of Clinical Oncology. 30:607-611
The efficacy and safety of definitive chemoradiotherapy (CRT) for elderly patients with esophageal cancer have not been fully elucidated yet. We conducted a retrospective comparison of the outcomes of CRT between elderly and nonelderly patients with
Autor:
Kiyomi Mera, Yoshinori Miyata, Yasuhiro Shimada, Kuniaki Shirao, Yasuhide Yamada, Atsushi Ohtsu, Tomonori Yano, Tetsuya Hamaguchi, Yusuke Tanigawara, Kei Muro, Narikazu Boku, Toshihiko Doi, Manabu Muto
Publikováno v:
Japanese Journal of Clinical Oncology. 36:218-223
Infusional fluorouracil (5-FU) and leucovorin (LV) with oxaliplatin is one of the current standard regimens for the treatment of patients with metastatic colorectal cancer. Weekly bolus 5-FU with high-dose LV (Roswell Park Memorial Institute Regimen:
Autor:
Atsushi Ochiai, Atsushi Ohtsu, Yukio Kobayashi, Ichiro Oda, Kensei Tobinai, Tadashi Yoshino, Satoshi Ishikura, Yoshihiro Matsuno, Shigeo Nakamura, Junji Suzumiya, Kiyomi Mera, Yasuhiko Kitadai, Takio Yokoi
Publikováno v:
Cancer Science. 97:163-166
Primary gastric diffuse large B-cell lymphomas are generally well controlled by non-surgical treatment with combination chemotherapy followed by radiotherapy. We have previously reported that over 90% of patients achieved complete response (CR) with
Autor:
Junko Iwasaki, Shigeaki Yoshida, Takahiro Fujii, Atsushi Ochiai, Kuang-I Fu, Tomonori Yano, Yasushi Sano, Kiyomi Mera, Takayuki Yoshino, Shigeharu Kato
Publikováno v:
Journal of Gastroenterology and Hepatology. 20:1572-1577
Background and Aim: Patients with multiple (hyperplastic polyposis) or large hyperplastic polyps (HPs) predominantly in the right-sided colon, have been reported to have an increased risk of colorectal cancer (CRC). This prospective study was conduct
Autor:
Narikazu Boku, Yoshikazu Kagami, Keiji Nihei, Shigeaki Yoshida, Yoshinori Ito, Atsushi Ohtsu, Satoshi Ishikura, Kiyomi Mera, Kuniaki Shirao, Kei Muro
Publikováno v:
Esophagus. 2:133-137
Background Nedaplatin is an analogue of cisplatin with less nonhematologic toxicity. The combination of nedaplatin and 5-fluorouracil showed a promising response rate in a previous phase II study for metastatic esophageal cancer. The purpose of this
Autor:
Satoshi Ishikura, Yoshio Tamaki, Tadashi Yoshino, Seiichiro Yamamoto, Kiyomi Mera, Shigeo Nakamura, Yoshikazu Kagami, Kuniaki Itoh, Masafumi Taniwaki, Junji Suzumiya, Atsushi Ohtsu, Toshiyuki Takagi, Ichiro Oda, Kensei Tobinai
Publikováno v:
Cancer Science. 96:349-352
CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) followed by radiotherapy is regarded as standard care for localized aggressive lymphoma; however, prospective confirmation of its applicability to localized primary gastric lymphoma is
Autor:
Shigeru Mikami, Kiyomi Mera, Junji Furuse, Hiroshi Ishii, Masahiro Yoshino, Hideki Sakai, Hiroaki Onaya, Haruhiko Nose, Yasushi Maru, Mitsuo Satake
Publikováno v:
American Journal of Clinical Oncology. 26:159-164
We prospectively evaluated the efficacy and safety of transcatheter arterial chemoembolization (TACE) with microembolization material, degradable starch microspheres (DSMs), and epirubicin, for treatment of multifocal hepatocellular carcinoma (HCC).
Autor:
Satoshi Ikeda, Tatsuhiro Arai, Hisateru Yasui, Kenichi Sugihara, Yutaka Ogata, Kenji Katsumata, Kiyomi Mera, Satoru Iwasa, Yoshitaka Inaba, Takeshi Kato, Tomoyuki Kato, Yasuhiro Shimada, Tetsuya Hamaguchi, Makoto Akaike
Publikováno v:
Journal of Integrative Oncology.
Background: This phase II study investigated the safety and efficacy of an oxaliplatin, fluorouracil, and lleucovorin regimen (FOLFOX6) in Japanese patients with previously untreated, unresectable metastatic colorectal cancer because oxaliplatin of F
Autor:
Shuichi Hironaka, Hisao Tajiri, Narikazu Boku, Shigeaki Yoshida, Motoki Yoshida, Atsushi Ohtsu, Manabu Muto, Fumio Nagashima, Kiyomi Mera, Makoto Tahara, Yasushi Sano
Publikováno v:
Gastric Cancer. 4:212-218
Background. Most gastric cancer patients with peritoneal dissemination have been excluded from clinical studies because they usually have no measurable lesions. They also have a high risk of toxicity because of complications such as intestinal obstru